MEK1/2 drugs for Melanoma

3 tracked MEK1/2 drugs in the Melanoma race. The class explanation lives on the MEK1/2 page; the full indication pipeline across every mechanism is on the Melanoma page.

3 approved / phase 4

Head-to-head evidence: Binimetinib vs Cobimetinib · Binimetinib vs Trametinib · Cobimetinib vs Trametinib

The roster

← all MEK1/2 drugs